GET THE APP

BACTERIOLOGY OF URINARY TRACT INFECTION AND ANTIBIOTIC SUSCEPTIBILITY PATTERN AMONG DIABETIC PATIENTS | Abstract
international journal of bioassays.
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

BACTERIOLOGY OF URINARY TRACT INFECTION AND ANTIBIOTIC SUSCEPTIBILITY PATTERN AMONG DIABETIC PATIENTS

Author(s): BL Chaudhary, Charu Chandra and Snehanshu Shukla

Abstract

Urinary tract infection is one of the most commonly occurring infections among the patients with diabetes mellitus. The present study was focused on the antibiotic susceptibility of the UTI pathogens isolated from the diabetic patients. A total 40 UTI organisms were isolated from 125 urine samples collected from the diabetic patients attending the Mayo Institute of Medical sciences, study period of six month from November, 2013 to may, 2014. The incidence of UTI was recorded to 32%. Escherichia coli (55%) was found to be the major cause of UTI. About 5 different types of organisms isolated from the UTI samples were randomly chosen to test against the UTI antibiotics of Himedia. The antibiotic susceptibility pattern revealed that GNB was most effective to imipenem 95.33%, gentamicin and nitrofurantoin 80%. GPC were most effective to vancomycin 100% tetracycline 85% and linezolid 83.5%. These data may be used to determine trends in antimicrobial susceptibilities, to formulate local antibiotic policies and to assist clinicians in the choice of antibiotic therapy to prevent misuse, or overuse, of antibiotics.

Share this article


International Journal of Bioassays is a member of the Publishers International Linking Association, Inc. (PILA), CROSSREF and CROSSMARK (USA). Digital Object Identifier (DOI) will be assigned to all its published content.

International Journal of Bioassays [ISSN: International Journal of Bioassays] is licensed under
Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
© Copyright 2012-2024. All rights reserved.